ES2152016T3 - Solucion oftalmica de pranoprofeno conteniendo amina organica. - Google Patents

Solucion oftalmica de pranoprofeno conteniendo amina organica.

Info

Publication number
ES2152016T3
ES2152016T3 ES96909378T ES96909378T ES2152016T3 ES 2152016 T3 ES2152016 T3 ES 2152016T3 ES 96909378 T ES96909378 T ES 96909378T ES 96909378 T ES96909378 T ES 96909378T ES 2152016 T3 ES2152016 T3 ES 2152016T3
Authority
ES
Spain
Prior art keywords
ophthalmic solution
pranoprophene
organic amine
present
amina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96909378T
Other languages
English (en)
Inventor
Shogo Miyagi
Yoshihide Horibe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2152016T3 publication Critical patent/ES2152016T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE SOLUCION OFTALMICA ES UNA SOLUCION OFTALMICA DE PRANOPROFENO QUE CONTIENE UNA AMINA ORGANICA. UNA SOLUCION OFTALMICA PREFERIDA ES UNA SOLUCION OFTALMICA DE PRANOPROFENO DEL 0,01 AL 0,5 % QUE CONTIENE DESDE UN 0,1 A UN 5,0 % DE LA AMINA ORGANICA. LA CONCENTRACION DE LA AMINA ORGANICA ES MAS PREFERIBLEMENTE DESDE UN 0,5 A UN 2,5 %. UN EJEMPLO PREFERIDO DE LA AMINA ORGANICA ES LA TROMETAMINA O 4 1 (2 BENZALCONIO DEL 0,002 AL 0,01 % A LA MISMA COMO CONSERVANTE. SEGUN LA PRESENTE INVENCION, SE DESCRIBE UNA SOLUCION OFTALMICA QUE POSEE EL PRANOPROFENO COMO PRINCIPIO ACTIVO, QUE NO PRESENTA CAMBIOS EN LA COMPOSICION, QUE OFRECE UNA ESTABILIDAD EXCELENTE Y QUE PRODUCE POCA IRRITACION A LOS OJOS.
ES96909378T 1995-04-20 1996-04-16 Solucion oftalmica de pranoprofeno conteniendo amina organica. Expired - Lifetime ES2152016T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09472395A JP3170619B2 (ja) 1995-04-20 1995-04-20 有機アミンを配合したプラノプロフェン点眼液

Publications (1)

Publication Number Publication Date
ES2152016T3 true ES2152016T3 (es) 2001-01-16

Family

ID=14118050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96909378T Expired - Lifetime ES2152016T3 (es) 1995-04-20 1996-04-16 Solucion oftalmica de pranoprofeno conteniendo amina organica.

Country Status (10)

Country Link
US (1) US6281224B1 (es)
EP (1) EP0824916B1 (es)
JP (1) JP3170619B2 (es)
AT (1) ATE196846T1 (es)
DE (1) DE69610622T2 (es)
DK (1) DK0824916T3 (es)
ES (1) ES2152016T3 (es)
GR (1) GR3034705T3 (es)
PT (1) PT824916E (es)
WO (1) WO1996032941A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US20020198174A1 (en) * 2001-05-07 2002-12-26 Allergan Sales, Inc. Disinfecting and solubilizing steroid compositions
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
KR100776579B1 (ko) * 2000-05-17 2007-11-15 센주 세이야꾸 가부시키가이샤 수성 액제
JP4707316B2 (ja) * 2002-10-11 2011-06-22 ロート製薬株式会社 水性液状組成物
ATE552838T1 (de) * 2003-11-14 2012-04-15 Senju Pharma Co Wässrige lösung mit aminoglykosid-antibiotikum und bromfenac
JP4789479B2 (ja) * 2004-02-23 2011-10-12 ロート製薬株式会社 プラノプロフェン含有水性組成物
JP2005239658A (ja) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd 点眼剤
JP5434981B2 (ja) * 2004-02-27 2014-03-05 大正製薬株式会社 点眼剤
JP4961671B2 (ja) * 2004-02-27 2012-06-27 大正製薬株式会社 点眼剤
JP2005239681A (ja) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd 眼科用剤
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
EP1808170B1 (en) * 2004-11-05 2011-08-17 Senju Pharmaceutical Co., Ltd. Aqueous eye drops with accelerated intraocular migration
US8030349B2 (en) * 2005-08-02 2011-10-04 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable medicament
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
JP5305710B2 (ja) * 2008-03-31 2013-10-02 株式会社ニデック ドルゾラミド塩酸塩点眼液
JP5992293B2 (ja) * 2012-10-31 2016-09-14 大正製薬株式会社 眼科用剤
CN105392481B (zh) * 2013-05-30 2018-10-12 千寿制药株式会社 两性离子性软性隐形眼镜用眼科用组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5195120A (en) * 1975-02-10 1976-08-20 Tenganekino seizoho
JPS5989616A (ja) * 1982-11-15 1984-05-23 Lion Corp 点眼液
JPS5989617A (ja) * 1982-11-15 1984-05-23 Lion Corp 点眼液
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPS6112617A (ja) * 1984-06-27 1986-01-21 Lion Corp 点眼液
US4696917A (en) 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
DE3612537C1 (de) 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
DE3612538A1 (de) 1986-04-14 1987-10-15 Dispersa Ag Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen
JPS6429170A (en) 1987-07-24 1989-01-31 Nec Corp Method and apparatus for recording dot picture
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
EP0501578A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
JPH05186349A (ja) * 1991-12-30 1993-07-27 Teika Seiyaku Kk プラノプロフェン点眼剤組成物
JPH0717863A (ja) * 1993-06-30 1995-01-20 Kaken Pharmaceut Co Ltd プラノプロフェン点眼液
JP3021312B2 (ja) * 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤

Also Published As

Publication number Publication date
JPH08291065A (ja) 1996-11-05
JP3170619B2 (ja) 2001-05-28
PT824916E (pt) 2001-01-31
EP0824916A1 (en) 1998-02-25
US6281224B1 (en) 2001-08-28
GR3034705T3 (en) 2001-01-31
EP0824916B1 (en) 2000-10-11
EP0824916A4 (en) 1999-06-16
DE69610622T2 (de) 2001-05-31
WO1996032941A1 (en) 1996-10-24
DE69610622D1 (de) 2000-11-16
ATE196846T1 (de) 2000-10-15
DK0824916T3 (da) 2001-02-05

Similar Documents

Publication Publication Date Title
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
AR247326A1 (es) Una composicion hipotonica acuosa para lentes de contacto.
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9714164A (pt) Novos derivados de ácido fluoracrìlico, novas misturas de herbicidas e antìdotos e seu emprego
ES2105913T3 (es) Composiciones para el teñido de las fibras queratinicas que comprenden un orto-diamino pirazol y una sal de manganeso, procedimiento de teñido que utiliza estas composiciones.
ES2148568T3 (es) Formulaciones de disoluciones acuosas estables de interferon alfa.
ES2055860T3 (es) Derivados 2-aminopirimidinona.
ES2169102T3 (es) (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
ES2158988T3 (es) Composiciones de aerosol.
ES8400241A1 (es) Procedimiento para la obtencion de medios antimicoticos con mayor liberacion de sustancia activa.
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
DE59909615D1 (de) Mittel zur abwehr und inaktivierung pathogener erreger von pflanzen
BR0012696A (pt) Composição oftálmica
ES2119046T3 (es) Compuestos dihalopropenos, insecticidas/acaricidas que los contienen como agentes activos y compuestos intermediarios para uso en su produccion.
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ES2145459T3 (es) Derivados de fenilalcanamidas y bactericidas agrohorticolas.
ES2169272T3 (es) Diaminopirimidinas, composiciones farmaceuticas que las contienen y su utilizacion como agente antibacteriano.
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 824916

Country of ref document: ES